Literature DB >> 32190616

Online cognitive behavior therapy for adolescents with excessive worry: a multiple baseline design feasibility study.

Tove Wahlund1,2, Maral Jolstedt1,2, Erik Andersson1, Sarah Vigerland1,2, Sean Perrin3, Lars-Göran Öst4, Jens Högström1,2, Eva Serlachius1,2.   

Abstract

BACKGROUND: One in twenty adolescents experience excessive worry and evidence-based psychological therapies are not sufficiently widespread to reach most of those affected. In this multiple baseline evaluation, we assess the feasibility and preliminary efficacy of a scalable, online cognitive-behavioral intervention for adolescents with excessive worry (BIP worry).
METHODS: Thirteen adolescents (age 13-17) with excessive worry underwent the 10-week online BIP worry intervention. The treatment also included an online intervention for parents. Completion rates, treatment satisfaction, and adverse events were measures of feasibility. Clinical outcomes included worry severity, symptoms of other anxiety and depression, and general functioning. To control for time and spontaneous fluctuations in symptoms, adolescents were randomized to a 2-, 6-, or 10-week baseline phase prior to treatment. A short measure of worry severity was administered weekly during the baseline and treatment phases. Outcomes were assessed before the baseline-phase, at pre-treatment, post-treatment, and at 1- and 3-month follow-ups.
RESULTS: Twelve of 13 included adolescents, together with their parents, participated in BIP worry, with a mean completion rate of 9.8 of the 10 treatment modules. Adolescents reported an average of 4.4 exposures per week as homework during treatment. High levels of treatment adherence, credibility, and satisfaction, and no serious adverse events were reported. Therapists averaged 21 min per week communicating with each family. Linear mixed effects models indicated significant improvements in worry, anxiety, and general functioning from pre- to post-treatment, with these gains maintained at 1- and 3-months follow-up. Reductions in worry severity during treatment were significantly larger than during the baseline phase. The results from the multiple baseline evaluation suggested an association between the introduction of the BIP worry intervention and subsequent symptom change for some but not all adolescents.
CONCLUSIONS: BIP worry is a feasible and potentially effective treatment. As the treatment is scalable and involves limited therapist contact, it represents a low-cost method for treating adolescents with excessive worry and anxiety. Further investigation under randomized controlled trial (RCT) conditions is warranted. 2020 mHealth. All rights reserved.

Entities:  

Keywords:  Adolescent; anxiety disorders; cognitive behavioral therapy (CBT); patient portals; treatment outcome

Year:  2020        PMID: 32190616      PMCID: PMC7063265          DOI: 10.21037/mhealth.2019.09.10

Source DB:  PubMed          Journal:  Mhealth        ISSN: 2306-9740


  31 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Adolescents' Daily Worry, Morning Cortisol, and Health Symptoms.

Authors:  Reout Arbel; Lauren Spies Shapiro; Adela C Timmons; Ilana Kellerman Moss; Gayla Margolin
Journal:  J Adolesc Health       Date:  2017-03-15       Impact factor: 5.012

Review 3.  The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science.

Authors:  Emily A Holmes; Ata Ghaderi; Catherine J Harmer; Paul G Ramchandani; Pim Cuijpers; Anthony P Morrison; Jonathan P Roiser; Claudi L H Bockting; Rory C O'Connor; Roz Shafran; Michelle L Moulds; Michelle G Craske
Journal:  Lancet Psychiatry       Date:  2018-03       Impact factor: 27.083

4.  Preliminary exploration of worry: some characteristics and processes.

Authors:  T D Borkovec; E Robinson; T Pruzinsky; J A DePree
Journal:  Behav Res Ther       Date:  1983

5.  The relationship between worry, rumination, and comorbidity: evidence for repetitive negative thinking as a transdiagnostic construct.

Authors:  Peter M McEvoy; Hunna Watson; Edward R Watkins; Paula Nathan
Journal:  J Affect Disord       Date:  2013-07-16       Impact factor: 4.839

6.  A children's global assessment scale (CGAS).

Authors:  D Shaffer; M S Gould; J Brasic; P Ambrosini; P Fisher; H Bird; S Aluwahlia
Journal:  Arch Gen Psychiatry       Date:  1983-11

7.  Generalized anxiety disorder: a preliminary test of a conceptual model.

Authors:  M J Dugas; F Gagnon; R Ladouceur; M H Freeston
Journal:  Behav Res Ther       Date:  1998-02

8.  The efficacy of a group-based, disorder-specific treatment program for childhood GAD--a randomized controlled trial.

Authors:  Monique C Holmes; Caroline L Donovan; Lara J Farrell; Sonja March
Journal:  Behav Res Ther       Date:  2014-08-20

9.  The Work and Social Adjustment Scale, Youth and Parent Versions: Psychometric Evaluation of a Brief Measure of Functional Impairment in Young People.

Authors:  Amita Jassi; Fabian Lenhard; Georgina Krebs; Martina Gumpert; Maral Jolstedt; Per Andrén; Martina Nord; Kristina Aspvall; Tove Wahlund; Chloe Volz; David Mataix-Cols
Journal:  Child Psychiatry Hum Dev       Date:  2020-06

10.  Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.

Authors:  Daniel Freeman; Graham Dunn; Helen Startup; Katherine Pugh; Jacinta Cordwell; Helen Mander; Emma Černis; Gail Wingham; Katherine Shirvell; David Kingdon
Journal:  Lancet Psychiatry       Date:  2015-03-31       Impact factor: 27.083

View more
  1 in total

1.  Italia Ti Ascolto [Italy, I am listening]: an app-based group psychological intervention during the COVID-19 pandemic.

Authors:  Laura Antonia Lucia Parolin; Ilaria Maria Antonietta Benzi; Erika Fanti; Alberto Milesi; Pietro Cipresso; Emanuele Preti
Journal:  Res Psychother       Date:  2021-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.